EVAX
Evaxion Biotech A/S
NASDAQ · Healthcare · Biotechnology · DK
$3.12
+1.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 102.33x
- P/S forward
- 43.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.73x
- Price / sales
- 3.47x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $19.1M
- EV / sales
- 2.55x
- EV / EBITDA
- -1.93x
- EV / EBIT
- -2.20x
- Market cap
- $26.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026